Boxer Capital, LLC’s Arcus Biosciences Inc Position
Does Boxer Capital, LLC own Arcus Biosciences Inc (RCUS)? Not currently — the last reported position was 1.60M shares worth $24M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$24M
Q3 2024
Shares
1.60M
% of Portfolio
+1.20%
Quarters Held
21
position exited
Position History RCUS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 1.60M | $24M | +1.20% |
| Q2 2024 | 1.60M | $24M | +1.29% |
| Q1 2024 | 1.60M | $30M | +1.49% |
| Q4 2023 | 1.60M | $31M | +1.53% |
| Q3 2023 | 1.60M | $29M | +1.53% |
| Q2 2023 | 1.60M | $32,541 | +1.51% |
| Q1 2023 | 1.43M | $26,123 | +1.28% |
| Q4 2022 | 1.43M | $30M | +1.56% |
| Q3 2022 | 1.43M | $37M | +2.11% |
| Q2 2022 | 1.43M | $36M | +2.30% |
| Q1 2022 | 1.43M | $45M | +2.32% |
| Q4 2021 | 1.43M | $58M | +2.25% |
| Q3 2021 | 2.08M | $73M | +2.54% |
| Q2 2021 | 2.08M | $57M | +2.02% |
| Q1 2021 | 2.08M | $59M | +1.99% |
| Q4 2020 | 2.08M | $54M | +1.74% |
| Q3 2020 | 2.08M | $36M | +1.23% |
| Q2 2020 | 2.08M | $52M | +2.27% |
| Q1 2020 | 3.08M | $43M | +2.92% |
| Q4 2019 | 1.67M | $17M | +0.96% |
| Q3 2019 | 300.0K | $3M | +0.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of RCUS.